The role of survivin expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma

European Journal of Surgical Oncology

Volumn 33, Issue 2, 2007, Pages 229-233

  Marioni, G ^a   Pillon, M ^a   Bertolin, A ^a   Staffieri, A ^a   Marino, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Differential diagnosis; Laryngeal; Papillary hyperplasia; Survivin; Verrucous squamous cell carcinoma

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLOTTIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, VERRUCOUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847356985     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.027     Document Type: Article

References (15)

1. Orvidas L.J., Olsen K.D., Lewis J.E., and Suman V.J. Verrucous carcinoma of the larynx: a review of 53 patients. Head Neck 20 (1998) 197-203
2. Thompson L.D.R. Diagnostically challenging lesions in head and neck pathology. Eur Arch Otorhinolaryngol 254 (1997) 357-366
3. Koch B.B., Trask D.K., Hoffman H.T., et al. for the Commission on Cancer at the American College of Surgeons and the American Cancer Society. National survey of head and neck verrucous carcinoma. Patterns of presentation, care, and outcome. Cancer 92 (2001) 110-120
4. Nemoto T., Kitagawa M., Hasegawa M., et al. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 76 (2004) 253-259
5. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22 (2003) 8581-8589
6. Dong Y., Sui L., Watanabe Y., Sugimoto K., and Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 22 (2002) 2377-2383
7. Sharma H., Sen S., Mathur M., Bahadur S., and Singh N. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 26 (2004) 733-740
8. Marioni G., Ottaviano G., Marchese-Ragona R., et al. High nuclear expression of apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma. Acta Otolaryngol (Stockh) 126 (2006) 197-203
9. Marioni G, Marino F, Bertolin A, et al. Survivin expression in laryngeal squamous cell carcinomas and neck lymph node metastases. Anticancer Res, in press.
10. Pizem J., Cör A., and Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 45 (2004) 180-186
11. Rosai J. Larynx and trachea. In: Rosai J. (Ed). Ackerman's surgical pathology. 9th ed. (2004), Mosby, St. Louis, MO 335-346
12. Impola U., Uitto V.J., Hietanen J., et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202 (2004) 14-22
13. Li F., Yang J., Ramnath N., Javle M.M., and Tan D. Nuclear or cytoplasmic expression of survivin: What is the significance?. Int J Cancer 114 (2005) 509-512
14. Grabowski P., Kühnel T., Mühr-Wilkenshoff F., et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88 (2003) 115-119
15. Kimmich T., and Kleinsasser O. Benign keratoma of the vocal cords. Eur Arch Otorhinolaryngol 250 (1993) 143-149